A flow reactor system for providing on-demand H.sub.2 evolution at pressure from a liquid organic hydrogen carrier and/or blends thereof includes a reactor that includes a reaction vessel having an inlet and outlet. The inlet is configured to introduce reactants into the reaction vessel, and the outlet is configured to release reaction products. The reaction vessel is configured to hold therein a catalyst system capable of catalyzing the evolution of molecular hydrogen from a liquid organic hydrogen carrier. Advantageously, the reaction vessel is configured to operate at pressures greater than or equal to 50 psig (e.g., from about 50 psig to about 10500 psig. The flow reactor system also includes a source of preheated liquid organic hydrogen carrier in fluid communication with the reactor and a purification system in fluid communication with the outlet that provides purified molecular hydrogen gas for on-demand applications.

A method for controlling temperature of a chemical reaction without measuring a temperature of the chemical reaction. Changes in mass of a chemical reaction are monitored and are used to calculate the temperature of the system. The reaction can be maintained at a desired temperature (T) without measuring the temperature. The disclosed method is useful for reactions that occur at non-equilibrium conditions where any measured temperature would presume steady-state conditions.

A catalytic reactor comprises a load distributor assembly to evenly transfer a load from equipment (internals) to a reactor support ring or support structure fixed within the reactor shell, thereby maximizing the possible load to be applied to the support ring or support structure without any hot-work modifications and without exceeding the allowable tensions/stress.

A fuel tank inerting system includes a primary catalytic reactor comprising an inlet, an outlet, a reactive flow path between the inlet and the outlet, and a catalyst on the reactive flow path. The catalytic reactor is arranged to receive fuel from the fuel tank and air from an air source that are mixed to form a combined flow, and to react the combined flow along the reactive flow path to generate an inert gas. The system also includes an input sensor that measures a property of the combined flow before it enters the primary catalytic reactor and an output sensor that measures the property of the combined flow after it exits the primary catalytic reactor.

A fuel tank inerting system includes a primary catalytic reactor comprising an inlet, an outlet, a reactive flow path between the inlet and the outlet, and a catalyst on the reactive flow path. The catalytic reactor is arranged to receive fuel from the fuel tank and air from an air source that are mixed to form a combined flow, and to react the combined flow along the reactive flow path to generate an inert gas. The system also includes an input sensor that measures a property of the combined flow before it enters the primary catalytic reactor and an output sensor that measures the property of the combined flow after it exits the primary catalytic reactor.

A bi-modal radial flow reactor comprising a cylindrical outer housing surrounding at least five cylindrical, concentric zones, including at least three annulus vapor zones and at least two catalyst zones. The at least two catalyst zones comprise an outer catalyst zone and an inner catalyst zone. The at least three annulus vapor zones comprise an outer annulus vapor zone, a middle annulus vapor zone, and a central annulus vapor zone, wherein the central annulus vapor zone extends along a centerline of the bi-modal radial flow reactor. The outer catalyst zone is intercalated with the outer annulus vapor zone and the middle annulus vapor zone, and the inner catalyst zone is intercalated with the middle annulus vapor zone and the central annulus vapor zone. A removable head cover can be fixably coupled to a top of the cylindrical outer housing to seal a top of the bi-modal radial flow reactor.

A process and system for the conversion of a feedstock comprising C3-C5 light alkanes to a C5+ hydrocarbon product, for example, a BTX-rich hydrocarbon product, by performing the alkane activation (first-stage) and the oligomerization/aromatization (second-stage) in separate stages, which allows each conversion process to occur at optimal reaction conditions thus increasing the overall hydrocarbon product yield. The alkane activation or first-stage is operated at a higher temperature than the second-stage since light alkanes are much less reactive than light olefins. Since aromatization of olefins is more efficient at higher pressure, the second-stage is maintained at a higher pressure than the first-stage. Further, fixed-bed catalysts are used in each of the first-stage and the second-stage.

A process and system for the conversion of a feedstock comprising C3-C5 light alkanes to a C5+ hydrocarbon product, for example, a BTX-rich hydrocarbon product, by performing the alkane activation (first-stage) and the oligomerization/aromatization (second-stage) in separate stages, which allows each conversion process to occur at optimal reaction conditions thus increasing the overall hydrocarbon product yield. The alkane activation or first-stage is operated at a higher temperature than the second-stage since light alkanes are much less reactive than light olefins. Since aromatization of olefins is more efficient at higher pressure, the second-stage is maintained at a higher pressure than the first-stage. Further, fixed-bed catalysts are used in each of the first-stage and the second-stage.

The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NO.sub.2 to NO, including exhaustion of consumable reactants of the cartridge reactor. Accordingly, various embodiments of the present invention provide systems and methods of determining the remaining useful life of a NO.sub.2-to-NO reactor cartridge and/or a breakthrough of NO.sub.2, and providing an indication of the remaining useful life and/or breakthrough.

The principles and embodiments of the present invention relate to methods and systems for safely providing NO to a recipient for inhalation therapy. There are many potential safety issues that may arise from using a reactor cartridge that converts NO.sub.2 to NO, including exhaustion of consumable reactants of the cartridge reactor. Accordingly, various embodiments of the present invention provide systems and methods of determining the remaining useful life of a NO.sub.2-to-NO reactor cartridge and/or a breakthrough of NO.sub.2, and providing an indication of the remaining useful life and/or breakthrough.